Acronis Disk Director 12 Crack Serial Key odyjai
یکلسهارت فارتسی. Next Generation Business Intelligence, no downloading is required to continue your work - access the new free Acronis Disk Director 12 now! Would you like to continue? Yes No Thank you for choosing Acronis Sending... If you experience any problems please contact us at [email protected] or click the help icon on the toolbar.Reoperation after arthroscopic rotator cuff repair: a systematic review. In the literature, the majority of studies reported a low reoperation rate after arthroscopic rotator cuff repair. However, a systematic review of reoperations after arthroscopic repair of the rotator cuff was not published. Our objective was to conduct a systematic review of the reoperation rate after arthroscopic repair of the rotator cuff. A systematic review was performed. An electronic search of PubMed, Embase, and Cochrane Library was conducted. The search terms included "rotator cuff," "reoperation," "revision," and "subsequent operation." The references of the selected articles were scanned for possible inclusion. Inclusion criteria were articles published between January 1966 and May 2007 in English and available on full-text review. The primary outcome was reoperation rate. Thirty-two studies with a total of 3092 patients met the inclusion criteria. The mean follow-up was 26 months (range, 3-110 months). Reoperation rate was 1.9% for patients undergoing repair in primary care and 3.7% for patients requiring revision. The reoperation rate was higher in older patients, in those with a single tear, with type I or type III lesions, or in those with a history of prior repair. The reoperation rate was lower in large tears, in those with a positive preoperative supraspinatus muscle belly sign, and in patients undergoing repair in a specialist unit. The majority of reoperations were acromioplasties or proximal row carpectomies (50%). Arthroscopic rotator cuff repair has a low reoperation rate. Careful patient selection and repair technique are important factors to prevent recurrent tears. Therapeutic Level IV.